Remarkable prognostic heterogeneity justifies subdividing high-risk gastrointestinal stromal tumors (GIST) of NIH consensus scheme into two different risk groups

被引：0
|
作者：
Li, CF
Huang, WW
Lin, CN
Lu, D
Huang, HY
机构：
[1] Chi Mei Fdn Med Ctr, Tainan, Taiwan
[2] Natl Cheng Kung Univ, Coll Med, Tainan 70101, Taiwan
[3] Chang Gung Mem Hosp, Kaohsiung, Taiwan
来源：
LABORATORY INVESTIGATION | 2006年 / 86卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
509
引用
收藏
页码：112A / 112A
页数：1
相关论文
共 50 条
  • [1] Remarkable prognostic heterogeneity justifies subdividing high-risk gastrointestinal stromal tumors (GIST) of NIH consensus scheme into two different risk groups
    Li, CF
    Huang, WW
    Lin, CN
    Lu, D
    Huang, HY
    MODERN PATHOLOGY, 2006, 19 : 112A - 112A
  • [2] Genetic heterogeneity of high risk gastrointestinal stromal tumor (GIST)
    Nishida, Toshirou
    Naito, Yoichi
    Honma, Yoshitaka
    Hirota, Seiichi
    Ichikawa, Hitoshi
    CANCER SCIENCE, 2018, 109 : 762 - 762
  • [3] Gastrointestinal stromal tumors (GIST): A prospective evaluation of risk factors and prognostic scores
    Sanchez Hidalgo J.M.
    Rufian Peña S.
    Ciria Bru R.
    Naranjo Torres A.
    Muñoz Casares C.
    Ruiz Rabelo J.
    Briceño Delgado J.
    Journal of Gastrointestinal Cancer, 2010, 41 (1) : 27 - 37
  • [4] Prognostic stratification of high-risk gastrointestinal stromal tumors in the era of targeted therapy
    Park, Cheol Keun
    Lee, Eui Jin
    Kim, Minji
    Lim, Ho-Yeong
    Choi, Dong Il
    Noh, Jae Hyung
    Sohn, Tae Sung
    Kim, Sung
    Kim, Mi Jung
    Lee, Hun Kyung
    Kim, Kyoung-Mee
    ANNALS OF SURGERY, 2008, 247 (06) : 1011 - 1018
  • [5] Gastrointestinal stromal tumors (GIST) of the small bowel: High-risk pathologic features predict the need for adjuvant therapy
    Hassan, Imran
    You, Yi-Qian N.
    Shyyan, Roman
    Dozois, Eric J.
    Okuno, Scott H.
    Smyrk, Thomas C.
    Donohue, John H.
    GASTROENTEROLOGY, 2006, 130 (04) : A890 - A890
  • [6] Multidetector CT of high-risk patients with occult gastrointestinal stromal tumors
    Nishida, T
    Kumano, S
    Sugiura, T
    Ikushima, H
    Nishikawa, K
    Ito, T
    Matsuda, H
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2003, 180 (01) : 185 - 189
  • [7] Neoadjuvant gleevec is effective in the treatment of high-risk gastrointestinal stromal tumors
    Arciero, C
    Watson, JC
    ANNALS OF SURGICAL ONCOLOGY, 2006, 13 (02) : 28 - 29
  • [8] Comparison of different risk classification systems in patients with high risk gastrointestinal stromal tumors
    Yin, Y.
    Cai, Z.
    Zhang, B.
    Shen, C.
    ANNALS OF ONCOLOGY, 2018, 29
  • [9] A Novel Pathological Prognostic Score (PPS) to Identify "Very High-Risk" Patients: a Multicenter Retrospective Analysis of 506 Patients with High Risk Gastrointestinal Stromal Tumor (GIST)
    Liu, Xuechao
    Qiu, Haibo
    Wu, Zhiming
    Zhang, Peng
    Feng, Xingyu
    Chen, Tao
    Li, Yong
    Tao, Kaixiong
    Li, Guoxin
    Sun, Xiaowei
    Zhou, Zhiwei
    JOURNAL OF GASTROINTESTINAL SURGERY, 2018, 22 (12) : 2150 - 2157
  • [10] A Novel Pathological Prognostic Score (PPS) to Identify “Very High-Risk” Patients: a Multicenter Retrospective Analysis of 506 Patients with High Risk Gastrointestinal Stromal Tumor (GIST)
    Xuechao Liu
    Haibo Qiu
    Zhiming Wu
    Peng Zhang
    Xingyu Feng
    Tao Chen
    Yong Li
    Kaixiong Tao
    Guoxin Li
    Xiaowei Sun
    Zhiwei Zhou
    Journal of Gastrointestinal Surgery, 2018, 22 : 2150 - 2157
12345